EXOSF Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained top-line expansion across 2020–2025 demonstrates durable demand for Exosens' specialized photonics products across defense, industrial and scientific end markets. Persistent revenue growth supports multi-year program visibility and underpins investment in R&D and capacity planning.
Strong Operating ProfitabilityHigh EBITDA margins in 2024–2025 indicate structural operating leverage in Exosens' business model and value capture on specialized components. Durable margin capability supports reinvestment, program qualification efforts, and resilience through procurement cycles if maintained.
Marked DeleveragingMaterial reduction in leverage over multiple years strengthens balance-sheet flexibility, lowers interest burdens and improves capacity to fund working capital or pursue strategic opportunities. Improved solvency reduces refinancing risk into the medium term.
Bears Say
Sharp Gross‑Margin CompressionA sudden, large decline in gross margin signals structural mix shifts, pricing pressure, or cost increases that materially reduce durable profitability. If sustained, this erodes the company’s ability to fund R&D, sustain high operating margins and meet multi-year margin expectations.
Weaker Free‑Cash‑Flow ConversionA meaningful drop in free cash flow and lower FCF conversion versus net income increases funding uncertainty for capital needs and shareholder returns. Volatile cash generation reduces the predictability of reinvestment and heightens sensitivity to working‑capital swings.
Modest Net Margins And VolatilityDespite healthy EBITDA, net margins are modest, limiting retained earnings for growth or buffering downturns. Combined with margin volatility, this constrains long-term capital allocation flexibility and raises the firm's sensitivity to cost, pricing or demand shocks.
Exosens News
EXOSF FAQ
What was Exosens’s price range in the past 12 months?
Currently, no data Available
What is Exosens’s market cap?
Exosens’s market cap is $3.36B.
When is Exosens’s upcoming earnings report date?
Exosens’s upcoming earnings report date is Jul 28, 2026 which is in 15 days.
How were Exosens’s earnings last quarter?
Exosens released its earnings results on Feb 23, 2026. The company reported $0.85 earnings per share for the quarter, beating the consensus estimate of N/A by $0.85.
Is Exosens overvalued?
According to Wall Street analysts Exosens’s price is currently Undervalued.
Does Exosens pay dividends?
Exosens does not currently pay dividends.
What is Exosens’s EPS estimate?
Exosens’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Exosens have?
Exosens has 50,936,750 shares outstanding.
What happened to Exosens’s price movement after its last earnings report?
Exosens reported an EPS of $0.85 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Exosens?
Currently, no hedge funds are holding shares in EXOSF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Exosens
Exosens specializes in the development, production, and global distribution of advanced electro-optical technologies. Its core expertise lies in amplification, detection, and imaging solutions, catering to markets across France, the rest of Europe, North America, Asia, Oceania, and Africa, as well as other international territories. The company's extensive product portfolio features image intensifier tubes; a diverse array of cameras covering ultraviolet, short-wave, long-wave, visible-near infrared, and mid-wave infrared spectra; and enhanced vision equipment. Exosens further provides ion, electron, scintillation, and single photon detection products; X-ray components, neutronic imaging systems, and image intensifiers tailored for scientific applications; alongside gamma and neutron detectors, and mineral insulated extensions. Additionally, it supplies power tubes, microwave devices, and airborne solutions for methane detection. Operating under prominent brands including Photonis, Xenics, Telops, and El-Mul, Exosens serves vital sectors such as defense and surveillance, industrial research and control, life science and environmental monitoring, and the nuclear industry. Established in 1937 and headquartered in Mérignac, France, Exosens functions as a subsidiary of HLD Europe S.C.A.
EXOSF Stock 12 Month Forecast
Average Price Target
$75.74
X-Fab Silicon Foundries SE
―
MEMSCAP SA
―
Lacroix Group SA
―
Adeunis RF SA
―
Embention Sistemas Inteligentes SA
―
Ownership Overview
―
Insiders
5.04% Mutual Funds
― Other Institutional Investors
88.28% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---